Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RPS6KA2 | Q15349 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16701290 | 1.00 | ALDH1A1 (0.66) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL4573543 | 0.89 | ALDH1A1 (0.69) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL4573547 | 0.89 | ALDH1A1 (0.69) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL16204409 | 0.83 | MAPT (0.55) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL16197764 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL3941177 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL29746037 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL10689999 | 0.81 | ALDH1A1 (0.64) | ALDH1A1MAPTRAB9AKDM4EHPGD | |
| SCHEMBL13232278 | 0.80 | ALDH1A1 (0.75) | ALDH1A1MAPTRAB9AKDM4ERPS6KA2 | |
| SCHEMBL18263606 | 0.80 | ALDH1A1 (0.63) | ALDH1A1MAPTRAB9ARPS6KA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3065740-B1 | NOVEL OXAZOLIDINONE ANTIBACTERIAL COMPOUND | LEE PHARMA LTD (IN) | 2018-08-22 | — | — | EP | claimed |
| US-9573910-B2 | Oxazolidinone antibacterial compound | LEE PHARMA LIMITED (IN) | 2017-02-21 | — | — | US | claimed |
| US-20160272597-A1 | Novel Oxazolidinone Antibacterial Compound | LEE PHARMA LIMITED (IN) | 2016-09-22 | — | — | US | claimed |
| EP-3065740-A1 | NOVEL OXAZOLIDINONE ANTIBACTERIAL COMPOUND | Lee Pharma Ltd. (IN) | 2016-09-14 | — | — | EP | claimed |
| WO-2015068173-A1 | NOVEL OXAZOLIDINONE ANTIBACTERIAL COMPOUND | LEE PHARMA LIMITED (IN) | 2015-05-14 | — | — | WO | claimed |
| WO-2015068171-A1 | NOVEL OXAZOLIDINONE COMPOUNDS | LEE PHARMA LIMITED (IN) | 2015-05-14 | — | — | WO | claimed |
| EP-3065740-B1 | NOVEL OXAZOLIDINONE ANTIBACTERIAL COMPOUND | LEE PHARMA LTD (IN) | 2018-08-22 | — | — | EP | disclosed |
| US-9573910-B2 | Oxazolidinone antibacterial compound | LEE PHARMA LIMITED (IN) | 2017-02-21 | — | — | US | disclosed |
| US-20160272597-A1 | Novel Oxazolidinone Antibacterial Compound | LEE PHARMA LIMITED (IN) | 2016-09-22 | — | — | US | disclosed |
| EP-3065740-A1 | NOVEL OXAZOLIDINONE ANTIBACTERIAL COMPOUND | Lee Pharma Ltd. (IN) | 2016-09-14 | — | — | EP | disclosed |
| WO-2015068173-A1 | NOVEL OXAZOLIDINONE ANTIBACTERIAL COMPOUND | LEE PHARMA LIMITED (IN) | 2015-05-14 | — | — | WO | disclosed |
| WO-2015068171-A1 | NOVEL OXAZOLIDINONE COMPOUNDS | LEE PHARMA LIMITED (IN) | 2015-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272597-A1 | Novel Oxazolidinone Antibacterial Compound | OXA1L, ODC1, AZI2 | ALDH1A1 2873/4885MAPT 4185/4885RAB9A 3752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.